Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Colorcon
Farmers Insurance
Citi
QuintilesIMS
Mallinckrodt
Queensland Health
Covington
Johnson and Johnson
Merck

Generated: February 17, 2018

DrugPatentWatch Database Preview

HALDOL Drug Profile

« Back to Dashboard

Drug patent expirations by year for HALDOL
Pharmacology for HALDOL
Medical Subject Heading (MeSH) Categories for HALDOL

US Patents and Regulatory Information for HALDOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ortho Mcneil HALDOL haloperidol lactate CONCENTRATE;ORAL 015922-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-003 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Janssen Pharms HALDOL haloperidol decanoate INJECTABLE;INJECTION 018701-002 Jan 31, 1997 AO RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-004 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Janssen Pharms HALDOL haloperidol lactate INJECTABLE;INJECTION 015923-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Janssen Pharms HALDOL haloperidol decanoate INJECTABLE;INJECTION 018701-001 Jan 14, 1986 AO RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-006 Feb 2, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ortho Mcneil Pharm HALDOL SOLUTAB haloperidol TABLET;ORAL 017079-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for HALDOL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Ortho Mcneil HALDOL haloperidol lactate CONCENTRATE;ORAL 015922-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-004 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Janssen Pharms HALDOL haloperidol lactate INJECTABLE;INJECTION 015923-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-006 Feb 2, 1982 ➤ Sign Up ➤ Sign Up
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-005 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Ortho Mcneil HALDOL haloperidol TABLET;ORAL 015921-003 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Citi
Deloitte
Federal Trade Commission
Johnson and Johnson
Cantor Fitzgerald
Fish and Richardson
Covington
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot